Table 2 Univariate logistic regression analysis between early systolic blood pressure drop and worsening renal function

Age, yrs

0.98

0.92–1.04

0.5

Male, yes = 1, no = 0

0.69

0.34–1.42

0.3

Body weight at assessment, kg

0.99

0.96–1.02

0.4

Clinical scenario 1, yes = 1, no = 0

1.42

0.64–3.18

0.4

Clinical scenario 2, yes = 1, no = 0

1 (Ref.)

–

–

Clinical scenario 3, yes = 1, no = 0

1.04

0.27–3.99

0.96

Clinical scenario 4, yes = 1, no = 0

1.33

0.43–4.08

0.6

Ejection fraction, %

0.18

0.96–1.01

0.2

Current smoking, yes = 1, no = 0

1.16

0.53–2.57

0.7

Daily alcohol intake, yes = 1, no = 0

0.14

0.15–1.32

0.1

Hypertension, yes = 1, no = 0

3.48

1.02–11.8

0.046

Diabetes mellitus, yes = 1, no = 0

0.97

0.46–2.06

0.9

Lipid disorder, yes = 1, no = 0

1.23

0.62–2.58

0.5

Chronic atrial fibrillation, yes = 1, no = 0

0.91

0.39–2.12

0.8

 Log BNP

1.36

0.97–1.91

0.08

 Hemoglobin, g/dL

0.97

0.82–1.15

0.7

 BUN, mg/dL

0.997

0.98–1.02

0.8

 Serum creatinine, g/dL

1.12

0.83–1.53

0.5

 ACEI use, yes = 1, no = 0

0.29

0.04–2.20

0.2

 ARB use, yes = 1, no = 0

1.42

0.70–2.89

0.3

 CCB use, yes = 1, no = 0

0.83

0.40–1.72

0.6

 Beta-blocker, yes = 1, no = 0

1.47

0.70–3.01

0.3

 Loop diuretics, yes = 1, no = 0

1.48

0.73–3.04

0.3

 I.V. loop diuretic use, yes = 1, no = 0

2.93

0.99–8.65

0.052

 I.V. isosorbide dinitrate, yes = 1, no = 0

3.18

1.54–6.58

0.002

 I.V. carperitide use, yes = 1, no = 0

0.66

0.15–3.01

0.6

 Systolic blood pressure at admission, mmHg

1.02

1.01–1.03

0.001

 Diastolic blood pressure at admission, mmHg

1.01

0.99–1.03

0.5

 Heart rate at admission, mmHg

0.987

0.97–0.999

0.046

 Early systolic blood pressure drop, mmHg

1.02

1.01–1.03

0.001